Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo.
暂无分享,去创建一个
W. R. Bishop | P. Kirschmeier | Ming Liu | B. Long | Gongjie Liu | Cindy H Marrinan | L. Nale | S. Taylor | W. Bishop